These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9838312)

  • 1. In vitro pretransplant mixed lymphocyte culture response and acute rejection episodes.
    Agrawal S; Singh AK; Sharma RK; Gupta A; Kumar A; Kapoor R; Bhandari M
    Transplant Proc; 1998 Nov; 30(7):2974. PubMed ID: 9838312
    [No Abstract]   [Full Text] [Related]  

  • 2. Pretransplant CD4 helper function and interleukin 10 response predict risk of acute kidney graft rejection.
    Weimer R; Zipperle S; Daniel V; Carl S; Staehler G; Opelz G
    Transplantation; 1996 Dec; 62(11):1606-14. PubMed ID: 8970616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute rejection episodes predict long-term renal transplantation survival.
    Kokado Y; Takahara S; Hatori M; Ichimaru I; Wang JD; Miki T; Okuyama A
    Transplant Proc; 1997; 29(1-2):1537-40. PubMed ID: 9123416
    [No Abstract]   [Full Text] [Related]  

  • 4. Postrenal transplant MLR hypo-responders have fewer rejections and better graft survival than MLR hyper-responders.
    Kerman RH; Susskind B; Katz SM; Van Buren CT; Kahan BD
    Transplant Proc; 1997; 29(1-2):1410-1. PubMed ID: 9123358
    [No Abstract]   [Full Text] [Related]  

  • 5. The clinical relevance of pretransplant recipient immunoresponsiveness in renal transplantation: impact on rejection.
    Renna Molajoni E; Cinti P; Evangelista B; Poli L; Cocciolo P; Berloco P; Cortesini R
    Transplant Proc; 1996 Feb; 28(1):402-3. PubMed ID: 8644290
    [No Abstract]   [Full Text] [Related]  

  • 6. Possible role of post renal transplant graft-versus-host antibodies in preventing acute graft rejection.
    Jakab J; Borka P; Hoffer I; Perner F; Gyódi E; Rajczy K; Petrányi G; Szabó J
    Transplant Proc; 1998 Dec; 30(8):3981-3. PubMed ID: 9865269
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary tacrolimus immunosuppression in kidney recipients considered "higher immunologic risk".
    Braun F; Lorf T; Schütz E; Canelo R; Hanack U; Döpkens K; Sattler B; Grupp C; Ringe B
    Transplant Proc; 2000 Nov; 32(7):2535. PubMed ID: 11120281
    [No Abstract]   [Full Text] [Related]  

  • 8. Relative contribution of HLA disparity to chronic allograft nephropathy.
    Baltzan MA; Shoker AS; Baltzan MA
    Transplant Proc; 2002 Dec; 34(8):3125-7. PubMed ID: 12493395
    [No Abstract]   [Full Text] [Related]  

  • 9. One HLA haplo-identical transfusion in first renal allograft recipients: effect on alloimmunisation, acute rejection episodes, and graft survival.
    Bayle F; Masson D; Zaoui P; Janbon B; Bensa JC; Vialtel P
    Transplant Proc; 1995 Aug; 27(4):2457-8. PubMed ID: 7652881
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of acute rejection on long-term graft survival in HLA-identical living-related kidney transplants.
    Al-Kerithy M; Salazar A; Kiberd B; Bitter-Suermann H; MacDonald AS; Lawen JG
    Transplant Proc; 2001 Sep; 33(6):2982-3. PubMed ID: 11543820
    [No Abstract]   [Full Text] [Related]  

  • 11. Benefits of HLA-CREG matching for sensitized recipients as illustrated in kidney regrafts.
    Takemoto SK; Cecka JM; Terasaki PI
    Transplant Proc; 1997; 29(1-2):1417. PubMed ID: 9123361
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations.
    Emiroğlu R; Yagmurdur MC; Karakayali F; Haberal C; Ozcelik U; Colak T; Haberal M
    Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretransplant and posttransplant monitoring of anti-HLA class I IgG1 antibodies by ELISA identifies patients at high risk of graft loss.
    Monteiro F; Mineiro C; Rodrigues H; de Paula FJ; Kalil J
    Transplant Proc; 1997; 29(1-2):1433-4. PubMed ID: 9123368
    [No Abstract]   [Full Text] [Related]  

  • 14. Crossmatching for renal transplantation--a 5-year review of different cytotoxic and flow cytometric methods showing importance of the IgG anti-B-lymphocyte FACS crossmatch.
    Horsburgh T; Lycett A; Mistry N; Nicholson M; Underwood I; Veitch PS; Weston S
    Transplant Proc; 1997; 29(1-2):1458-9. PubMed ID: 9123380
    [No Abstract]   [Full Text] [Related]  

  • 15. Pretransplant flow cytometry crossmatch in first cadaveric kidney transplants.
    Mascaretti L; Sioli V; Puglisi G; Rossini G; Trezzi D; Scarpino C; Scalamogna M; Sirchia G
    Transplant Proc; 1995 Feb; 27(1):668-70. PubMed ID: 7879138
    [No Abstract]   [Full Text] [Related]  

  • 16. Does lymphocyte cross-matching predict acute rejection and graft survival in liver transplantation?
    Joo DJ; Ju MK; Huh KH; Kim MS; Choi GH; Choi JS; Jeon KO; Kim SI
    Transplant Proc; 2012 Mar; 44(2):418-20. PubMed ID: 22410032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
    Reissi D; Bardideh A; Samadzadeh B; Razi A
    Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
    [No Abstract]   [Full Text] [Related]  

  • 18. Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression.
    van der Mast BJ; van Besouw NM; de Kuiper P; Vaessen LM; Gregoor PJ; IJzermans JN; van Gelder T; Claas FH; Weimar W
    Transplantation; 2001 Sep; 72(5):873-80. PubMed ID: 11571453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of pretransplant allosensitization with severity of rejection biopsy.
    Clark J; Kerman R; Susskind B; Katz S; Van Buren C; Kahan B
    Transplant Proc; 1999; 31(1-2):751-2. PubMed ID: 10083321
    [No Abstract]   [Full Text] [Related]  

  • 20. Living-related versus living-unrelated kidney transplantation using tacrolimus initial immunosuppression.
    Braun F; Canelo R; Lorf T; Schütz E; Grupp C; Müller GA; Ringe B
    Transplant Proc; 2000 Feb; 32(1):115-6. PubMed ID: 10700989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.